ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Zydus Therapeutics
This role involves managing all aspects of site monitoring activities, including conducting Site Qualification, Initiation, Periodic, and Close-out Visits in compliance with ICH/GCP principles. The position serves as the primary contact for assigned sites, ensuring protocol adherence, patient safety, and proper investigational product management. The role also requires supporting functional groups with safety data reporting and providing guidance to prevent noncompliance.
Headquarters
Pennington, New Jersey, United States
Zydus Therapeutics is a clinical-stage, specialty-focused biopharmaceutical company dedicated to developing transformative treatments for rare and serious liver diseases. As a subsidiary of Zydus Lifesciences, the company leverages a research team of 1,300 scientists and is currently enrolling patients in two late-stage clinical trials, including studies on Primary Biliary Cholangitis (PBC) and NASH. Its pipeline includes Saroglitazar Mg, which has received FDA Fast Track Designation for PBC treatment.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Zydus Therapeutics.
14% above the average for this role